PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA SPÓŁKA AKCYJNA
Copy
CopyKey data
Status
KRS number
CopyREGON
CopyNIP/VAT code
CopyVAT registration date
VAT status
Bankruptcy proceedings
PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA SPÓŁKA AKCYJNA
Contacts
Registered address
Copy
Website
HTTP://WWW.JELFA.COM.PL
A
HighestReliability
A - HighestIncorporation date
04/12/2001Share capital
27,316,160.00 PLNPrimary activity
Manufacture of pharmaceutical preparations (21.20.Z - PKD 2007)Representatives
0Representatives rights
DO SKŁADANIA OŚWIADCZEŃ WOLI I PODPISYWANIA W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.Representatives
No representativesBusiness linkages
Premium users: 1.00 credit
Financial report (Okredo)
Premium users: 1.00 credit
People
Representatives
Person  | Title |
|---|---|
- | - |
Persons with Significant Control
Persons with Significant Control
This information is available in our reports and to subscription users.Financial ratios
Net Profit (zł)
6,266,480Net Profit (zł)
6,266,480Financial report (Okredo)
Premium users: 1.00 credit
| Indicator |
|---|
| Turnover (zł) |
| Profit before tax (zł) |
| Net Profit (zł) |
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business. |
| Liquidity ratioliquidityRatio |
| Net profitability (%)This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales. |
| Equity (zł) |
| Current liabilities (zł) |
| Non current liabilities (zł) |
| Non-current Assets (zł) |
| 2022 |
|---|
| 200,120,417 |
| 126,607,541 |
| 118,340,600 |
| 2.20 |
| 11.97 |
| 59.13 |
| 1,125,691,635 |
| 40,075,112 |
| 216,251 |
| 96,454,041 |
| 2023 |
|---|
| 256,667,505 |
| -8,611,806 |
| -16,476,129 |
| 1.87 |
| 15.23 |
| -6.42 |
| 1,109,221,636 |
| 33,704,515 |
| 306,787 |
| 95,099,750 |
| 2024 |
|---|
| 255,694,175 |
| 16,397,977 |
| 6,266,480 |
| 2.11 |
| 18.92 |
| 2.45 |
| 1,115,689,435 |
| 30,172,924 |
| 668,719 |
| 93,620,979 |
| 2024 |
|---|
| 255,694,175 |
| 16,397,977 |
| 6,266,480 |
| 2.11 |
| 18.92 |
| 2.45 |
| 1,115,689,435 |
| 30,172,924 |
| 668,719 |
| 93,620,979 |
Turnover (zł)
2024
Turnover (zł)
255,694,175 zł
0 % *
Profit before tax (zł)
16,397,977 zł
290 % *
Net Profit (zł)
6,266,480 zł138 % *
Working capital requirement (%)
2.11 
12.83 % *
Liquidity ratio
18.92 24.23 % *
Net profitability (%)
2.45 %138.16 % *
Equity (zł)
1,115,689,435 zł1 % *
Current liabilities (zł)
30,172,924 zł-10 % *
Non current liabilities (zł)
668,719 zł118 % *
Non-current Assets (zł)
93,620,979 zł
-2 % *
Credit history
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
No. of unpaid debts
0
Largest debt
-
Amount of unpaid debts
€0.00
Oldest open debt
-
Credit report
Creditor/Data source | Debt amount | Debt date | Debt type |
|---|---|---|---|
- | - | - | - |
Creditor/Data source | Debt amount | Debt date | Payment date | Debt type |
|---|---|---|---|---|
- | - | - | - | - |
Documents
PRZEDSIĘBIORSTWO FARMACEUTYCZNE JELFA SPÓŁKA AKCYJNA Documents
Date | Description |
|---|---|
02/07/2025 | OD 01.01.2024 DO 31.12.2024 |
18/09/2024 | OD 01.01.2023 DO 31.12.2023 |
21/09/2023 | OD 01.01.2022 DO 31.12.2022 |
20/12/2022 | OD 01.01.2021 DO 31.12.2021 |
19/10/2021 | OD 01.01.2020 DO 31.12.2020 |